Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute release_og6fpj5b2jg2vk4br6sns5e4dm

by John D. Hainsworth, Dana S. Thompson, John A. Bismayer, Victor G. Gian, William M. Merritt, Robert C. Whorf, Lindsey H. Finney, B. Stephens Dudley

Published in Cancer Medicine by Wiley.

2014   p673-681

Archived Files and Locations

application/pdf  380.5 kB
file_cwn2xdijnvgorcc5opomygcjka
europepmc.org (repository)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2014-12-31
Language   en ?
DOI  10.1002/cam4.376
PubMed  25556916
PMC  PMC4430260
Wikidata  Q35602123
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  2045-7634
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 9eba80ef-98cc-4063-9a82-8cdb7ac4b2b7
API URL: JSON